Cellosaurus cell line Hewga-CCS (CVCL

Cellosaurus Hewga-CCS (CVCL_0J32)

Cross-references
Cell line name	Hewga-CCS
Accession	CVCL_0J32
Resource Identification Initiative	To cite this cell line use: Hewga-CCS (RRID:CVCL_0J32)
Comments	Population: Japanese. Doubling time: ~44 hours (PubMed=24946937). Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
Sequence variations	Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF; Note=Type 2: EWSR1 exon 7 fused to ATF1 exon 5 (PubMed=24946937; PubMed=28745431).
Disease	Clear cell sarcoma of soft tissue (NCIt: C3745) Soft tissue sarcoma (ORDO: Orphanet_3394)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell	Female
Age at sampling	34Y
Category	Cancer cell line
Publications	PubMed=24946937; DOI=10.1186/1471-2407-14-455; PMCID=PMC4076438 Outani H., Tanaka T., Wakamatsu T., Imura Y., Hamada K.-i., Araki N., Itoh K., Yoshikawa H., Naka N. Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS. BMC Cancer 14:455.1-455.13(2014) PubMed=28745431; DOI=10.1002/cam4.1130; PMCID=PMC5603837 Nakai T., Imura Y., Tamiya H., Yamada S., Nakai S., Yasuda N., Kaneko K., Outani H., Takenaka S., Hamada K., Myoui A., Araki N., Ueda T., Itoh K., Yoshikawa H., Naka N. Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma. Cancer Med. 6:2121-2130(2017)
Encyclopedic resources	Wikidata; Q54883210
Entry history
Entry creation	10-Apr-2015
Last entry update	19-Dec-2024
Version number	10